Logo
  • About
  • Contact
  • (888) 441-8033

RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications

NEW ALBANY, Ind. -- RxLightning, creator of the industry’s first comprehensive platform for streamlining specialty medication access and affordability, today announced that it closed a $17.5 million Series A investment to support the company’s growth and further remove barrier...

View full release

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (Nasdaq:BPTH) Q1 23

DALLAS, TX -- June 2nd, 2023 --  Bio-Path Holdings, Inc. (Nasdaq:BPTH): The full report can be accessed by clicking on the following link: BPTH Q1 23 Report Awaiting Topline Results in Several Key Cohorts Ongoing Clinical Trials: The Company has various product candidates in...

View full release

Stonegate Capital Partners Updates Coverage on Pathfinder Bancorp, Inc. (Nasdaq:PBHC) Q1 2023

DALLAS, TX -- June 2nd, 2023 -- Pathfinder Bancorp, Inc. (Nasdaq:PBHC): Stonegate Capital Partners updates coverage on Pathfinder Bancorp, Inc. (Nasdaq:PBHC). The full report can be accessed by clicking on the following link: PBHC Q1 23 Report Company Summary Pathfinder Bank...

View full release

Lumotive Partners with Hokuyo to Revolutionize 3D Lidar Sensing for Industrial Automation

REDMOND, Wash. and OSAKA, Japan -- June 1, 2023 -- Lumotive, a company specializing in Light Control Metasurface (LCM™) beam steering chips for advanced 3D optical sensors, and Hokuyo Automatic Co., Ltd., a worldwide producer of sensor and automation technology, have revealed ...

View full release

Stonegate Healthcare Partners Announces Publishing of a Thematic Report - Beyond VEGF: Therapies Revolutionizing Diabetic Eye Disease

Dallas, TX - June 1, 2023 - Stonegate Healthcare Partners (SHP), a healthcare strategy consulting firm, is pleased to announce the release of a thematic report that examines innovative advancements in the treatment of diabetic eye disease, including diabetic retinopathy (DR) a...

View full release

MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems

Boston, MA - June 1, 2023 – Today, MatTek Life Sciences and AIM Biotech announced a strategic partnership through which the AIM Biotech portfolio will be available for sale through MatTek. Over the last thirty years, MatTek has become the leader in the advanced cell culture sp...

View full release

Stonegate Capital Partners Updates Its Coverage on ProStar Holdings Inc. (OTCQX: MAPPF) Q1 23

DALLAS, TX -- May 31st, 2023 -- ProStar Holdings Inc. (OTCQX: MAPPF): Stonegate Capital Partners updates coverage on ProStar Holdings Inc. (OTCQX: MAPPF). The full report can be accessed by clicking on the following link: MAPS Q1 23 Report Company Summary Expansion Is Leading...

View full release

Pacylex Pharmaceuticals to Attend 2023 BIO International Convention

Edmonton, Alberta, Canada/May 31, 2023- Pacylex Pharmaceuticals, a clinical-stage company developing PCLX-001, a first-in-class oral investigational small molecule for leukemia, lymphoma, and solid tumor cancers, today announced that it will be attending the Biotechnology Inno...

View full release

Stonegate Capital Partners Updates Coverage on Borqs Technologies Inc. (NASDAQ: BRQS) 2H 2022

DALLAS, TX -- May 30th, 2023 --  Borqs Technologies Inc. (NASDAQ: BRQS): Stonegate Capital Partners updates their coverage on Borqs Technologies Inc. The full report can be accessed by clicking on the following link: https://stonegateinc.com/download/brqs-2h-2022/?wpdmdl=570&r...

View full release

Stonegate Initiates Coverage on Electro Optics Systems Holdings Ltd (ASX: EOS)

DALLAS, TX -- May 30th, 2023 --  Electro Optics Systems Holdings Ltd (ASX: EOS): Stonegate Capital Partners initiates their coverage on Electro Optics Systems Holdings Ltd (ASX: EOS). The full report can be accessed by clicking on the following link: EOS.AX Initiation Report C...

View full release
  • « First
  • ‹ Prev
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy